Funding Details
- Awarder
- Gaingels
- Date Award
- May 24, 2024
- Vertical
- Healthcare and Biotech
- Funding URL
- View Funding Page
- Valuation
-
$250,000,000
Company Info
- Founders
- Mark Rus
- Company Description
- Based on the discovery of a novel class of neuroplasticity-promoting therapeutics known as psychoplastogens, Delix is building a company to find solutions for CNS-related diseases.. Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.
- Market
- Healthcare & Wellness
- Coinvestors
- ARTIS Ventures
Links